These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 28573430)

  • 21. Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertension.
    Ranasinghe ADCU; Schwarz MA
    Biochem Pharmacol; 2022 Oct; 204():115245. PubMed ID: 36096239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.
    Archer SL; Marsboom G; Kim GH; Zhang HJ; Toth PT; Svensson EC; Dyck JR; Gomberg-Maitland M; Thébaud B; Husain AN; Cipriani N; Rehman J
    Circulation; 2010 Jun; 121(24):2661-71. PubMed ID: 20529999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic roles in the malignant transformation of gastric mucosal cells.
    Tie J; Zhang X; Fan D
    Cell Mol Life Sci; 2016 Dec; 73(24):4599-4610. PubMed ID: 27464701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes.
    Urvalek A; Laursen KB; Gudas LJ
    Subcell Biochem; 2014; 70():129-49. PubMed ID: 24962884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetics: novel mechanism of pulmonary hypertension.
    Huang JB; Liang J; Zhao XF; Wu WS; Zhang F
    Lung; 2013 Dec; 191(6):601-10. PubMed ID: 24052023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension.
    Gerthoffer W
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications.
    Lu J; Huang Y; Zhang X; Xu Y; Nie S
    Pharmacol Res; 2021 Aug; 170():105520. PubMed ID: 33639232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis.
    Bure IV; Nemtsova MV; Kuznetsova EB
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension.
    Thompson AAR; Lawrie A
    Trends Mol Med; 2017 Jan; 23(1):31-45. PubMed ID: 27989641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetics and vascular diseases.
    Stratton MS; Farina FM; Elia L
    J Mol Cell Cardiol; 2019 Aug; 133():148-163. PubMed ID: 31211956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms.
    Stanzione R; Cotugno M; Bianchi F; Marchitti S; Forte M; Volpe M; Rubattu S
    Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31941075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment.
    Wołowiec Ł; Mędlewska M; Osiak J; Wołowiec A; Grześk E; Jaśniak A; Grześk G
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role for DNA damage signaling in pulmonary arterial hypertension.
    Meloche J; Pflieger A; Vaillancourt M; Paulin R; Potus F; Zervopoulos S; Graydon C; Courboulin A; Breuils-Bonnet S; Tremblay E; Couture C; Michelakis ED; Provencher S; Bonnet S
    Circulation; 2014 Feb; 129(7):786-97. PubMed ID: 24270264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway.
    Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L
    J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signals and combinatorial functions of histone modifications.
    Suganuma T; Workman JL
    Annu Rev Biochem; 2011; 80():473-99. PubMed ID: 21529160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in Epigenetics of Depression.
    Peña CJ; Nestler EJ
    Prog Mol Biol Transl Sci; 2018; 157():41-66. PubMed ID: 29933956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension.
    Ho L; Hossen N; Nguyen T; Vo A; Ahsan F
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways.
    Liu Y; Cao Y; Sun S; Zhu J; Gao S; Pang J; Zhu D; Sun Z
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):141-154. PubMed ID: 27297622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetics of Huntington's Disease.
    Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M
    Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.